Diuretics for heart failure

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 4, 2016, Pages

  Faris, Rajaa F ^a   Flather, Marcus ^b,e   Purcell, Henry ^c   Poole Wilson, Philip A ^d   Coats, Andrew Js ^b  

^a PRINCE SULTAN CARDIAC CENTER   (Saudi Arabia)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

^d NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^e NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT;

HEART FAILURE; HUMAN; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; DISEASE COURSE; META ANALYSIS; MORTALITY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

DISEASE PROGRESSION; DIURETICS; HEART FAILURE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84962659738     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003838.pub4     Document Type: Review

References (82)

1. Barr CS, Lang CC, Hanson J, Arnott M, Kennedy N, Struthers AD. Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease. American Journal of Cardiology 1995;76:1259-65.
2. Boccanelli A, Zachara E, Liberatore SM, Carboni GP, Prati PL. Addition of captopril versus increasing diuretics in moderate but deteriorating heart failure: a double-blind comparative trial. Postgraduate Medical Journal 1986;62(Suppl 1):184-87.
3. Burr ML, King S, Davies HE, Pathy MS. The effects of discontinuing long-term diuretic therapy in elderly. Age & Ageing 1977;6:38-45.
4. Cheitlin MD, Byrd R, Benowitz N, Liu E, Modin G. Amiloride improves hemodynamics in patients with chronic congestive heart failure treated with chronic digoxin and diuretics. Cardiovascular Drugs & Therapy 1991;5:719-26.
5. Cowley AJ, Stainer K, Wyne RD, Rowley JM, Hampton JR. Symptomatic assessment of patients with heart failure: double-blind comparison of increasing doses of diuretics and captopril in moderate heart failure. Lancet 1986;2:770-72.
6. Dalhstrom UF, Areskog M, Wranne B, Karlsson E. Prenalterol as a long therapy for chronic congestive heart failure: a randomised cross-over trial with intensified diuretics. Acta Med Scand 1986;216(2):199.
7. De Jong JW, Knottnerus JA, van Zutphen WM, De Bruijne GA, Struijker Boudier HA. Short-term effect of withdrawal of diuretic drugs prescribed for ankle oedema. BMJ 1994;308:511-13.
8. Haerer W, Hetzel M, Fehske KL, Fehske KL, Stauch M. The impact of digoxin and diuretics on exercise tolerance in congestive heart failure: a placebo controlled randomised double-blind trial. Circulation 1989;80:1698A.
9. Myers MG, Weingert ME, Fisher RH, Gryfe CI, Schulman HS. Unnecessary diuretic therapy in the elderly. Age & Ageing 1982;11:213-21.
10. Nordrehaug JK, Omsjo IH, Vollset SE. A 3-month double-blind cross-over study of the effect of Benazepril and hydrochlorothiazide on functional class in symptomatic mild heart failure. Journal of Internal Medicine 1992;231:589-94.
11. Richardson A, Bayliss J, Scriven AJ, Sutton GC, Poole-Wilson PA. Double-blind comparison of captopril alone against furosemide plus amiloride in mild heart failure. Lancet 1987;2(8561):709-11.
12. Sherman LG, Liang CS, Baumgardner S, Charuzi Y, Chardo F, Kim CS. Peritanide, a potent diuretic with potassium-sparing properties, for treatment of congestive heart failure. Clinical Pharmacology & Therapeutics 1986;40(5):587-94.
13. Sievert H, Offerman T, Kaltenbach M, Kaltenbach M, Bussmann WD. Basic therapy of chronic heart failure with digitalis or diuretics? [Basistherapie der chronischen Herzinsuffizienz mit Digitalis oder Diuretika?]. Deutsche Medizinische Wochenschrift 1989;114(10):363-67.
14. Walma EP, Hoes AW, van Dooren C, Prins A, van der Does E. Withdrawal of long-term diuretic medication in elderly patients: a double-blind randomised trial. BMJ 1997;315:464-68.
15. Abbondati G, Cavalli A, Fuccella LM, Riva E, Schleman M, Tournadre P, et al. Ibopamine versus hydrochlorothiazide/amiloride in patients with mild congestive heart failure. Cardiovascular Drugs & Therapy 1989;3:897-902.
16. Andrews R, Charlesworth A, Evans E, Cowley AJ. A double-blind, cross-over comparison of the effects of a loop diuretic and a dopamine receptor agonist as first line therapy in patients with mild congestive heart failure. European Heart Journal 1997;18:852-57.
17. Edhago, Furhoff AK, Gertz I, Kilbom A, Lunman T, Michaeli E, et al. Ethacrynic acid in pulmonary oedema. Lakartindingen 1967;64(Suppl 4):85-7.
18. Pitt B, Remme W, Zannad F, James Neaton J, Martinez F, Roniker B, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction (EPHESUS). New England Journal of Medicine 2003;348(14):1309-21.
19. Grinstead WC, Francis MJ, Marks GF, Tawa CB, Zoghbi WA, Young JB. Discontinuation of chronic diuretic therapy in stable congestive heart failure secondary to coronary artery disease or to idiopathic dilated cardiomyopathy. American Journal of Cardiology 1994;73:881-6.
20. Haerer W, Baure U, Sultan N, Cernoch K, Mouselimis N, Fehske KJ, et al. Acute and chronic effects of a diuretic monotherapy with piretanide in congestive heart failure: a placebo-controlled trial. Cardiovascular Drugs & Therapy 1990;4(2):515-21.
21. Kleber FX, Thyroff-Friesinger U. Treatment of mild chronic congestive heart failure with ibopamine, hydrochlorothiazide, ibopamine plus hydrochlorothiazide or placebo. A double-blind comparative study. Cardiology 1990;77(Suppl 5):67-74.
22. Kourouklis C, Christensen O, Augoustakis D. Bumetanide in congestive heart failure. Current Medical Research & Opinion 1976;4:422-31.
23. Mathur BN, Pugsley SO, Powles AC, McEwan MP, Campbell AJ. Effect of diuretics on cardiopulmonary performance in severe chronic airflow obstruction. A controlled clinical trial. Archives of Internal Medicine 1984;144:2154-57.
24. Parker JO. The effects of oral ibopamine in patients with mild heart failure: a double-blind placebo controlled comparison to furosemide. International Journal of Cardiology 1993;40(3):221-7.
25. Patterson JH, Adams KF, Applefeld MM, Corder CN, Masse BR. Oral torsemide in patients with chronic congestive heart failure: effects on body weight, oedema, and electrolyte excretion. Pharmacotherapy 1994;14(5):514-21.
26. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. New England Journal of Medicine 1999;341:709-719.
27. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. ACC/AHA 2009 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation.. J Am Coll Cardiology 2009;53(15):e1-e90.
28. Ahmend A, Husain A, Love TE, Gambassi G, DellItalia LJ, Francis GS, et al. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. European Heart Journal 2006;27(12):1431-9.
29. Furberg CD, Wright Jr JT, Davis BR, Cutler JA, Alderman M, Black H, et al. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker versus diuretic: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 2002;288:2981-97.
30. Anand IS, Kalra GS, Harris P, Poole-Wilson PA, Panzali A, De Guili F, et al. Diuretics as initial and sole treatment in chronic cardiac failure. Cardioscience 1991;2(4):273-8.
31. Aronow WS, Ahn C, Kronzon I. Prognosis of congestive heart failure in elderly patients with normal versus abnormal left ventricular systolic function associated coronary artery disease. American Journal of Cardiology 1990;6:1257-9.
32. Barr CS, Nass A, Freeman M. QT dispersion and sudden unexpected death in chronic heart failure. Lancet 1994;343:327-9.
33. Bayliss J, Norell M, Canepa-Anson R, Sutton G, Poole-Wilson PA. Untreated heart failure: clinical and endocrine effects of introducing diuretics. British Heart Journal 1987;57:17-22.
34. The Captopril-Digoxin Multicentre Research Group. Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. The Captopril-Digoxin Multicenter Research Group. JAMA 1988;259:539-44.
35. Chalmers I, Hetherington J, Elbourne D, Keirse MJNC, Enkin M. Materials and methods used in synthesizing evidence to evaluate the effects of care during pregnancy and childbirth. In: Chalmers I, Enkin M, Keirse MJNC editor(s). Effective Care in Pregnancy and Childbirth. Oxford: Oxford University Press, 1989:39-65.
36. Willenheimer, van Veldhuisen DJR, Silke B, Erdmann E, Follath F, et al. CIBIS III Investigators. Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III [Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III]. Circulation 2005 Oct 18;112((16)):2426-35.
37. Dargie HJ, Lechat P. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999;253:9-13.
38. Clarke M, Oxman AD editors. The Reviewers' Handbook. The Cochrane Library Issue 1 2003 [Updated November 2002]. The Cochrane Collaboration, 2002.
39. Cody RJ, Franklin KW, Laragh JH. Postural hypotension during tilt with chronic captopril and diuretic therapy of severe congestive heart failure. American Heart Journal 1982;103:480-4.
40. Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M, et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet 2003;362(9377):7-13.
41. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: Results of the cooperative North Scandinavian Enalapril Survival Study. New England Journal of Medicine 1987;316:1429-35.
42. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, et al. Effect of carvedilol on survival in severe chronic heart failure. New England Journal of Medicine 2001;344(22):1651-8.
43. Davie AP, Francis CM, Caruana L, Sutherland GR, McMurray JJ. The prevalence of left ventricular diastolic filling abnormalities in patients with suspected heart failure. European Heart Journal 1997;18:981-4.
44. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7:177-88.
45. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ 1994;309:1286-91.
46. Domanski M, Norman J, Pitt B, Haigney M, Hanlon S, Peyster E. Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD). Journal of the American College of Cardiology 2003;42:705-8.
47. El-Ebrashy N, El-Dansoury M, Higazi AM. Effects of digitalisation on urinary excretion of water, sodium, potassium, and chloride in heart failure. Journal of the Egyptian Medical Association 1968;51:638-44.
48. Farquharson CA, Struthers AD. Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I / angiotensin II conversion in patients with chronic heart failure. Circulation 2000;101(6):594-7.
49. Feigenbaum MS, Welsch MA, Mitchel M, Vincent K, Braith RW, Pepine CJ. Contracted plasma and blood volume in chronic heart failure. Journal of the American College of Cardiology 2000;35:51-5.
50. Flather MD, Yusuf S, Kober L, Pfeffer M, Hall A, Murray G, et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet 2000;35:1575-81.
51. Follath F. Do diuretics differ in terms of clinical outcome in congestive heart failure?. European Heart Journal 1998;19(Suppl P):P5-8.
52. Francis GS, Benedict C, Johnson DE. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 1990;82:1724-29.
53. Friedman LM, Furberg CD, DeMets DL. Fundamentals of clinical trials. 3rd Edition. New York: Springer-Verlag, 1998.
54. Grag R, Yusuf S. Overview of randomised trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaberative Group on ACE Inhibitors Trials. JAMA 1995;9(273):1450-6.
55. Hall SA, Cigarroe CG, Marcoux L, Risser RC, Grayburn PA, Eichhorn EJ. Time course of improvement in the left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. Journal of the American College of Cardiology 1995;25:1154-61.
56. Hollifield JW, Slaton PE. Thiazide diuretics, hypokalaemia and cardiac arrhythmias. Acta Medica Scandinavica 1981;209(647):67-73.
57. Iriarte M, Murga N, Sagastagoitia D, Molinero E, Morillas M, Salcedo A, et al. Congestive heart failure from left ventricular diastolic dysfunction in systemic hypertension. American Journal of Cardiology 1993;71:308-12.
58. J-MELODIC Program Committee. Rationale and design of a randomized trial to assess the effects of diuretics in heart failure: Japanese Multicenter Evaluation of Long- vs Short-Acting Diuretics in Congestive Heart Failure. Circulation Journal 2007;71(7):1137-40.
59. Klug D, Robert V, Swynghedauw B. Role of mechanical and hormonal factors in cardiac remodelling and the biologic limits of myocardial adaptation. American Journal of Cardiology 1993;71(3):46A-54A.
60. Lefebvre C, McDonald S. Development of a sensitive search strategy for reports of randomised controlled trials in EMBASE. Paper presented at Cochrane Colloquium, 20-24 Oct; Adelaide, Australia. 1996.
61. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 (updated Sept 2009). The Cochrane Collaboration, 2009. Available from www.cochrane-handbook.org.
62. Mantel N, Haenzel W. Statistical aspects of the analysis of data from retrospective studies of diseases.. In: Fleiss JL editor(s). Statistical methods for rates and proportion. 2nd Edition. Chichester: Wiley, 1981.
63. Hjalmarson A, Goldstein S, Fagerberg B, Wedel H, Waagstein F, Kjekshus J, et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized intervention trial in congestive heart failure (MERIT-HF). JAMA 2000;283(10):1295-302.
64. Motwani JG, Fenwick MK, Morton JJ, Struthers AD. Furosemide-induced natriuresis is augmented by ultra-low-dose captopril but not by standard doses of captopril in chronic heart failure. Circulation 1992;86:439-45.
65. Peart S, Brennan PJ, Broughton P, Dollery C, Hudson MF, Lever AF, et al. Medical Research Council trial of treatment of hypertension in older adults: Principal results. BMJ 1992;304:405-12.
66. Packer M, Medina N, Yushak M, Meller J. Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure. Circulation 1983;68:803-12.
67. Packer M, Lee WH, Medina N, Yushak M, Kessler PD. Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure. Annals of Internal Medicine 1987;106:346-54.
68. Pitt B. Effect of aldosterone blockade in patients with systolic left ventricular dysfunction: implications of the RALES and EPHESUS studies. Molecular and Cellular Endocrinology 2004;217(1-2):53-8.
69. Robson AO, Ashcoft R, Kerr DN, Teasdale G. The diuretic response to furosemide. Lancet 1964;2:1085-88.
70. Probstfield JL. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-64.
71. Slater JDH, Nabarro JDN. Clinical experience with chlorothiazide. Lancet 1958;1:124-26.
72. Steiness E, Olesen KH. Cardiac arrhythmias induced by hypokalaemia and potassium loss during maintenance digoxin therapy. British Heart Journal 1976;38:167-72.
73. Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991;338:1281-85.
74. Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administrations Co-operative study. New England Journal of Medicine 1986;314(24):1547-52.
75. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. Veterans Administration Co-operative study. New England Journal of Medicine 1991;325(5):303-10.
76. van Veldhusien DJ, Poole-Wilson PA. The under-reporting of results and possible mechanisms of 'negative' drug trials in patients with chronic heart failure. International Journal of Cardiology 2001;80(1):19-27.
77. Waagstein F, Bristow MR, Swedberg K, Camerini F, Fowler MB, Silver MA, et al. A Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. (MDC) Trial Study Group. Lancet 1993;342:1441-46.
78. Weber KT. Furosemide in the long-term management of heart failure: the good, the bad, and the uncertain. Journal of the American College of Cardiology 2004;44(6):1308-10.
79. Wilson JR, Reichek N, Dunkman WB, Goldberg S. Effect of diuresis on the performance of the failing left ventricle in man. American Journal of Medicine 1981;70:234-9.
80. Yusuf S. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. New England Journal of Medicine 1991;325:293-302.
81. Yusuf S, Nicklas JM, Timmis G, Breneman G, Jafri SM, Duvernoy WFC, et al. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. New England Journal of Medicine 1992;327:685-91.
82. Faris R, Flather MD, Purcell H, Henein MY, Poole-Wilson P, Coats AJS. Current evidence supporting the role of diuretics in heart failure: a meta-analysis of randomised controlled trials. International Journal of Cardiology 2002;82:149-58.